<- Go home

Added to YB: 2026-07-15

Pitch date: 2026-07-13

ACL.AX [bullish]

Australian Clinical Labs Limited

+1.33%

current return

Author Info

No bio for this author

Company Info

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs.

Market Cap

AUD 413.7M

Pitch Price

AUD 2.26

Price Target

N/A

Dividend

5.61%

EV/EBITDA

3.47

P/E

15.82

EV/Sales

0.96

Sector

Health Care Providers and Services

Category

special_situation

Show full summary:
3 more interesting ideas - Australian Clinical Labs Limited

ACL.AX: Aussie pathology provider at AUD 2.22, 13x NTM P/E, mkt cap AUD 412M, EV AUD 704M. Takeover probability now higher after appointing ex-Brookfield PE MD Greg Horan as CEO. Rising PE activity in Aussie healthcare space; competitor Healius fielding unsolicited bids for Agilex Biolabs.

Read full article (1 min)